Dear Members of the Englander Institute,
Congratulations to Dr. Jedd Wolchok, a highly esteemed physician-scientist who pioneered immunotherapy for the treatment of melanoma, on becoming the new Director of the Meyer Cancer Center! We look forward to expanding and deepening our partnership with the MCC under his new leadership.
Grace Le, a Cornell Tech grad student, spent several months earlier this year interning with our colleague Alex Sigaras, M.S. in the EIPM AI-XR Lab. We hope you enjoy learning more about her background and research interests in this article posted on the EIPM website.
July 28th was National Intern Day, and we celebrated by highlighting on our social media channels the current and former high school and college students who have participated in our joint Meyer Cancer Center/EIPM internship program. We wish all of them success in the future and thank the many staff members who volunteered their time to mentor the next generation of investigators.
We have several exciting new career opportunities at the EIPM, including Fellowships, new positions in informatics and computational biology, plus a few research technician openings. Please share this information within your professional networks so we can quickly staff up.
Thank you for your hard work and continued dedication to our mission, I hope you enjoy the rest of the summer.
Sincerely,
Olivier Elemento, Ph.D.
News Coverage & Awards
Congratulations to Valerie Gallegos, a Ph.D. student co-mentored by Dr. Laura Martin and myself on her new WCM CTSC TL1 Training Award to study the Influence of Senescent Fibroblasts on Patient-Derived Organoid Behavior & Drug Response!
Dr. Peter Martin was interviewed for the article “Real-World Treatment Outcomes With Transplantation and Maintenance Rituximab in Previously Untreated Patients With Mantle Cell Lymphoma,” which appeared in The ASCO Post on July 6th.
Dr. Bishoy M. Faltas published the following Expert Commentary in UroToday: “Using Immunohistochemistry for Practical Molecular Subtyping of Bladder Cancer,” on July 5th; “Understanding Mechanisms of Resistance to FGFR3 Inhibition in Bladder Cancer,” on July 7th; and “Non-Coding RNA Profiles as a Determinant of Prognosis in Non-Muscle-Invasive Micropapillary Bladder Cancer,” on July 13th.
Dr. John Leonard was interviewed on the Leukemia & Lymphoma Society podcast The Bloodline for the segment “Immune System To The Rescue: Immunotherapies In Blood Cancer,” on July 11th.
Clinical Director Dr. Cora N. Sternberg was interviewed for the news story, “No Longer ADT Alone in Metastatic Hormone-Sensitive Prostate Cancer, The ARASENS Trial,” by UroToday on July 14th.
Dr. Marcin Imieliński from WCM’s Pathology and Laboratory Medicine department, and affiliated with the New York Genome Center and the EIPM, was interviewed for the article, “A New Technology Could Help Solve a DNA Mystery,” in SciTechDaily on July 27th.
Dr. Lisa A. Newman from WCM’s Department of Surgery and the EIPM recently chaired an AACR steering committee that produced a report “AACR Cancer Disparities Progress Report 2022,” that was covered by the Oncology Times on July 20th.
Dr. Manish Shah was interviewed for the article, “Dr. Shah on the Importance of Genetic Testing in GI Cancer,” by OncLiveTV on July 6th.
Events
Our friends at the Meyer Cancer Center will hold a very special event, the Inaugural “Meyer Cancer Center 360” Symposium on Obesity and Cancer, with an amazing lineup of speakers including our colleague Dr. Jan Krumsiek and moderated by EIPM Member Dr. Kristy A. Brown. Register today for this August 4th event.
Thank you to our colleague Dr. Karsten Suhre for delivering a really interesting EIPM Seminar Series lecture, “Multiomics in the Middle East,” on July 12th.
I was honored to participate in the NCI Cancer Data Science webinar “AI-enabled multi-omic Precision Medicine, on July 13th.
Dr. Lisa A. Newman participated in a Society of Surgical Oncology panel discussion, “Responding to Racial Bias in Medicine,” on July 19th.
Upcoming Events:
A number of our EIPM colleagues will participate in September’s ImmunoRad Conference, including our Associate Director for Precision Immunology Dr. Laura Santambrogio, Dr. Monica Guzman, and organized by Dr. Lorenzo Galluzzi.
Publications
Clinical Director Dr. Cora N. Sternberg co-authored a number of papers recently including, “Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021,” in the July 2022 edition of European Urology; “The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy,” in the June 2022 edition of Molecular Oncology; “Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer,” in the June 2022 edition of Future Oncology; and “Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy,” in the July 2022 edition of the British Journal of Clinical Pharmacology.
“The landscape of metabolic brain alterations in Alzheimer’s disease,” by Dr. Richa Batra with Dr. Jan Krumsiek in Alzheimer’s & Dementia, July 13th.
“Mitochondrial control of inflammation,” was published by Dr. Lorenzo Galluzzi and WCM Department of Radiation Oncology colleagues in Nature Reviews Immunology on July 25th.
“The GA4GH Phenopacket schema defines a computable representation of clinical data,” co-authored by myself in Nature Biotechnology on June 15th.
“Larotrectinib in Mismatch-Repair-Deficient TRK Fusion-Positive Metastatic Colon Cancer After Progression on Immunotherapy,” was published by our Director for Liquid Biopsy Research Dr. Pashtoon Kasi in Cureus on July 7th. Dr. Kasi also co-authored “Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices,” in the Journal of Clinical Oncology on July 15th.
“Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution’s Experience,” was co-authored by our Scientific Director Dr. Massimo Cristofanilli in JCO Precision Oncology on June 30th.